Boston Partners’s Molina Healthcare MOH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-44,263
Closed -$7.68M 824
2025
Q4
$7.68M Sell
44,263
-5,452
-11% -$896K 0.01% 444
2025
Q3
$9.51M Sell
49,715
-510,346
-91% -$93.9M 0.01% 420
2025
Q2
$167M Sell
560,061
-13,162
-2% -$4.13M 0.19% 182
2025
Q1
$189M Sell
573,223
-381,947
-40% -$115M 0.23% 159
2024
Q4
$278M Sell
955,170
-327,798
-26% -$101M 0.34% 111
2024
Q3
$442M Buy
1,282,968
+251,448
+24% +$83M 0.52% 63
2024
Q2
$307M Buy
1,031,520
+232,570
+29% +$79M 0.38% 94
2024
Q1
$328M Buy
798,950
+103,245
+15% +$40M 0.39% 93
2023
Q4
$251M Sell
695,705
-212,386
-23% -$74.9M 0.33% 112
2023
Q3
$298M Sell
908,091
-7,770
-0.8% -$2.45M 0.41% 87
2023
Q2
$276M Buy
915,861
+634,279
+225% +$182M 0.37% 94
2023
Q1
$75.4M Buy
281,582
+35,256
+14% +$10.1M 0.1% 202
2022
Q4
$81.3M Sell
246,326
-14,207
-5% -$4.83M 0.11% 189
2022
Q3
$86.1M Sell
260,533
-599,351
-70% -$193M 0.13% 186
2022
Q2
$241M Sell
859,884
-33,746
-4% -$10.2M 0.34% 100
2022
Q1
$298M Buy
893,630
+6,204
+0.7% +$1.91M 0.36% 96
2021
Q4
$282M Sell
887,426
-18,230
-2% -$5.42M 0.34% 102
2021
Q3
$246M Buy
905,656
+21,663
+2% +$5.72M 0.31% 112
2021
Q2
$224M Buy
883,993
+14,945
+2% +$3.75M 0.29% 122
2021
Q1
$203M Buy
869,048
+63,081
+8% +$14.1M 0.27% 122
2020
Q4
$171M Buy
805,967
+3,647
+0.5% +$753K 0.27% 123
2020
Q3
$147M Sell
802,320
-32,311
-4% -$5.88M 0.27% 124
2020
Q2
$149M Sell
834,631
-13,507
-2% -$2.3M 0.27% 114
2020
Q1
$118M Sell
848,138
-49,984
-6% -$6.69M 0.24% 127
2019
Q4
$122M Sell
898,122
-29,190
-3% -$3.68M 0.16% 171
2019
Q3
$102M Buy
927,312
+348,151
+60% +$45.1M 0.14% 185
2019
Q2
$82.9M Buy
+579,161
New +$79.3M 0.11% 203

Other funds holding MOH

Boston Partners's MOH Position: Q1 2026 in Review

Boston Partners sold out of Molina Healthcare (MOH) in Q1 2026, closing a stake of 44,263 shares — an estimated $7.68M sold.

Boston Partners first reported a position in MOH in Q2 2019 and held it in 27 quarters. The position peaked at $442M in Q3 2024. 526 funds tracked by Wall St. Rank hold MOH as of Q1 2026.

  • Boston Partners reported no remaining Molina Healthcare position as of Q1 2026 after selling out during the quarter.
  • Boston Partners sold 44,263 Molina Healthcare shares in Q1 2026, an estimated $7.68M.
  • Boston Partners first reported a position in Molina Healthcare in Q2 2019 and held it in 27 quarters.
  • Boston Partners's Molina Healthcare position peaked at $442M in Q3 2024.
  • 526 funds tracked by Wall St. Rank held Molina Healthcare as of Q1 2026.

Based on Boston Partners's 13F filing for Q1 2026, filed 11 May 2026.